Global Engagement for health

What

Cities Changing Diabetes is a global health prevention program that targets urbanization health issues all over the world. The leading pharmaceutical company within diabetes, Novo Nordisk, has launched the CCD program in Mexico City, Tianjin, Houston, Copenhagen and Shanghai. The success depends on co-creation between local governments, academic institutions, NGO’s and treating centers. 

Challenge

How can the program management organization support local Novo Nordisk affiliates in setting up co-creation initiatives while at the same time creating a global vision build on evidence based insights from leading thinkers?

Response

Initiatives has developed the organizational structure for the CCD program organization that allows for an organic approach in the developing phase, while at the same time enabling knowledge and experience sharing among local affiliates and thereby co-creation among cities.